Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients.
Garvey
L J
LJ
Pflugrad
H
H
Thiyagarajan
A
A
Grover
V P B
VP
Taylor-Robinson
S D
SD
Winston
A
A
Clifford
David B
DB
Evans
Scott R
SR
D019380:Anti-HIV Agents / Q000627:therapeutic use; D003071:Cognition / Q000502:physiology; D003072:Cognition Disorders / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D056344:Executive Function / Q000502:physiology; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D016174:Hepacivirus / Q000502:physiology; D019698:Hepatitis C, Chronic / Q000150:complications / Q000503:physiopathology* / Q000821:virology; D006801:Humans; D009483:Neuropsychological Tests; D012367:RNA, Viral / Q000032:analysis; D014779:Virus Replication
D019380:Anti-HIV Agents; D012367:RNA, Viral